In this way, the intraperitoneal injection of IAPP aggregates from the pancreas homogenate to the transgenic mouse that expresses hIAPP, dramatically accelerates IAPP amyloid deposition, which was accompanied by abnormalities resembling T2DM (88, 89). The gene discussed is IAPP; the disease is type 2 diabetes mellitus.